via University of South Australia
University of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful condition which affects more than two million Australians and costs the country an estimated $23 billion a year.
Using new state-of-the-art imaging techniques to identify signs of osteoarthritis (OA), UniSA scientists are learning more about changes at the molecular level which indicate the severity of cartilage damage.
A study led by PhD student Olivia Lee and her supervisor Associate Professor Paul Anderson using mass spectrometry imaging (MSI) has mapped complex sugars on OA cartilage, showing different sugars are associated with damaged tissue compared to healthy tissue.
The finding will potentially help overcome one of the main challenges of osteoarthritis research – identifying why cartilage degrades at different rates in the body.
“Despite its prevalence in the community, there is a lot about osteoarthritis that we don’t understand,” Prof Anderson says.
“It is one of the most common degenerative joint diseases, yet there are limited diagnostic tools, few treatment options and no cure.”
Existing OA biomarkers are still largely focused on bodily fluids which are neither reliable nor sensitive enough to map all the changes in cartilage damage.
By understanding the biomolecular structure at the tissue level and how the joint tissues interact in the early stages of osteoarthritis, UniSA researchers say any molecular changes could be targeted to help slow the progression of the disease with appropriate medication or treatment.
Osteoarthritis affects an estimated 2.2 million Australians and more than 300 million people worldwide, with those aged over 45 most at risk. Being female, overweight, and having existing joint injuries increases the risk of getting OA.
In Australia, $3.75 million is spent on joint replacements alone for osteoarthritis patients each year, and other indirect costs related to lost work productivity and loss of wellbeing are estimated to be more than $23 billion a year.
In a recent paper published in the International Journal of Molecular Sciences, Lee and her colleagues from UniSA’s Musculoskeletal Biology Research Laboratory and the Future Industries Institute explore how advances in mass spectrometry imaging (MSI) to detect OA are promising.
“To date, diagnosing osteoarthritis has relied heavily on x-rays or MRI, but these provide limited information and don’t detect biomolecular changes that signal cartilage and bone abnormalities,” Lee says.
“By contrast, alternative imaging methods such as MSI can identify specific molecules and organic compounds in the tissue section.”
MSI has already demonstrated its strengths in identifying biomarkers for different types of cancer, and UniSA researchers are hopeful it can achieve the same for early diagnosis of osteoarthritis.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Osteoarthritis
- 'I'm a sexy grandma - people tell me I'm a literal goddess because of my online snaps'
Jacqueline Hooton, 61, from West Sussex, is a personal trainer who can lift double her body weight - but trolls still tell her to cover up and not wear shorts.
- Brixton Biosciences secures $33m to develop osteoarthritis pain platform
Brixton Biosciences has raised $33m to further develop Neural Ice, its pain management platform for osteoarthritis. Neural Ice physically induces a process called Wallerian degeneration when injected ...
- Are Diabetes Drugs Set to Move Osteoarthritis Management Forward?
Researchers are looking to see if GLP-1 receptor agonists, DPP4 inhibitors, and SGLT2 inhibitors have beneficial effects in osteoarthritis.
- Gait Alterations Linked to Worsening Pain and Physical Function in Knee Osteoarthritis
Researchers aimed to identify gait alterations related to worsening pain and physical function over 2 years among patients with or at risk for knee osteoarthritis.
- Blood test finds knee osteoarthritis up to eight years before it appears on X-rays: Study
A blood test successfully predicted knee osteoarthritis at least eight years before tell-tale signs of the disease appeared on x-rays, Duke Health researchers report. In a study appearing in ...
Go deeper with Google Headlines on:
Osteoarthritis
[google_news title=”” keyword=”osteoarthritis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Osteoarthritis biomarker
- Research validates anti-inflammatory properties of wine using urinary tartaric acid as biomarker
The anti-inflammatory effects of wine by analyzing the relationship between urinary tartaric acid concentrations and changes in serum inflammatory biomarkers.
- Blood test finds knee osteoarthritis up to eight years before it appears on X-rays: Study
A blood test successfully predicted knee osteoarthritis at least eight years before tell-tale signs of the disease appeared on x-rays, Duke Health researchers report. In a study appearing in ...
- Blood test detects knee osteoarthritis up to eight years before X-rays can - study
This is important because it provides more evidence that there are abnormalities in the joint that can be detected by blood biomarkers well before x-rays can detect OA,” Kraus said.
- This Common Condition Can Damage Joints Long Before It’s Detected
Nearly 33 million Americans have osteoarthritis. Experts explain how it affects the body, and why it’s so hard to diagnose.
- Research: Potential Biomarkers Located For Equine Osteoarthritis
New research suggests that microRNAs (miRNAs) found in blood and synovial fluid may be able to be used as biomarkers to evaluate joint health, reports Equine Science Update. MiRNAs regulate ...
Go deeper with Google Headlines on:
Osteoarthritis biomarker
[google_news title=”” keyword=”osteoarthritis biomarker” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]